Biased lead connector for operating room cable assembly and methods of making and using

Information

  • Patent Grant
  • 11951317
  • Patent Number
    11,951,317
  • Date Filed
    Wednesday, June 9, 2021
    2 years ago
  • Date Issued
    Tuesday, April 9, 2024
    a month ago
Abstract
An operating room cable assembly for an electrical stimulation system that includes a lead connector having a housing, a lead lumen extending inwardly from a first opening in the housing and configured and arranged to receive a portion of a lead or lead extension, and a contact assembly disposed within the housing and configured and arranged to move relative to the housing. The contact assembly is configured and arranged to move to a load position and is biased to return to a lock position. The contact assembly includes of contacts that are configured and arranged to engage a portion of any lead or lead extension within the lead lumen when the contact assembly is in the lock position and to disengage from the portion of the lead or lead extension within the lead lumen when the contact assembly is in the load position.
Description
FIELD

The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to a biased lead connector for an operating room cable assembly for use with an implantable electrical stimulation system, as well as methods of making and using the operating room cable assembly.


BACKGROUND

Implantable electrical stimulation systems have proven therapeutic in a variety of diseases and disorders. For example, spinal cord stimulation systems have been used as a therapeutic modality for the treatment of chronic pain syndromes. Peripheral nerve stimulation has been used to treat chronic pain syndrome and incontinence, with a number of other applications under investigation. Functional electrical stimulation systems have been applied to restore some functionality to paralyzed extremities in spinal cord injury patients. Stimulation of the brain, such as deep brain stimulation, can be used to treat a variety of diseases or disorders.


Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (with a pulse generator), one or more leads, and an array of stimulator electrodes on each lead. The stimulator electrodes are in contact with or near the nerves, muscles, or other tissue to be stimulated. The pulse generator in the control module generates electrical pulses that are delivered by the electrodes to body tissue.


BRIEF SUMMARY

One embodiment is an operating room cable assembly for an electrical stimulation system that includes a lead connector having a housing, a lead lumen extending inwardly from a first opening in the housing and configured and arranged to receive a portion of a lead or lead extension, and a contact assembly disposed within the housing and configured and arranged to move relative to the housing. The contact assembly is configured and arranged to move to a load position and is biased to return to a lock position. The contact assembly includes of contacts that are configured and arranged to engage a portion of any lead or lead extension within the lead lumen when the contact assembly is in the lock position and to disengage from the portion of the lead or lead extension within the lead lumen when the contact assembly is in the load position.


In at least some embodiments, the operating room cable assembly further includes a button coupled to the contact assembly, disposed within the housing, and movable relative to the housing, wherein the button is configured and arranged to move the contact assembly to the load position when the button is pushed and to return the contact assembly to the lock position when the button is released. In at least some embodiments, the button includes a carriage and the contact assembly is fastened to the carriage. In at least some embodiments, the carriage includes a lead engagement portion that is configured and arranged to engage the portion of the lead or lead extension in the lead lumen when the contact assembly is in the lock position to facilitate retention of the lead or lead extension.


In at least some embodiments, the operating room cable assembly further includes an elongated body coupled to, and extending from, the lead connector and including conductors with each of the conductors coupled to at least one of the contacts of the contact assembly of the lead connector. In at least some embodiments, the operating room cable assembly further includes a trial stimulator connector coupled to the elongated body and including at least one contact coupled to the conductors of the elongated body.


In at least some embodiments, the operating room cable assembly further includes at least one spring disposed between the contact assembly and the housing and configured and arranged to bias the contact assembly to the lock position. In at least some embodiments, the operating room cable assembly further includes a lead lumen housing disposed within the housing and defining at least a portion of the lead lumen. In at least some embodiments, the lead lumen housing further defines a plurality of contact openings that intersect the lead lumen and through which the contacts of the contact assembly can move between the load position and the lock position.


In at least some embodiments, the operating room cable assembly further includes a stylet lumen inwardly extending from a second opening in the housing opposite the lead lumen and intersecting the lead lumen. In at least some embodiments, the operating room cable assembly further includes a visually distinctive marking disposed on the housing around the first opening. In at least some embodiments, the contacts are “M” shaped pins. In at least some embodiments, the contact assembly includes a base with the contacts attached to the base. In at least some embodiments, the button includes a carriage and the base is part of the carriage.


Another embodiment is a trial stimulation system that includes a trial stimulator; and any of the operating room cable assemblies described above and coupleable, or coupled, to the trial stimulator. The trial stimulation system optionally includes a lead coupleable to the lead connector of the operating room cable assembly. The trial stimulation system optionally includes a lead extension coupleable to the lead and the lead connector of the operating room cable assembly.


A further embodiment is an insertion kit that includes any of the operating room cable assemblies described above and at least one electrical stimulation lead, each electrical stimulation lead having a distal end portion and a proximal end portion and including electrodes disposed along the distal end portion of the electrical stimulation lead, terminals disposed along the proximal end portion of the electrical stimulation lead, and conductors coupling the electrodes to the terminals, where the proximal end portion of the electrical stimulation lead is insertable into the lead connector of the operating room cable assembly.


Yet another embodiment is a method for performing a trial stimulation on a patient. The method includes providing any of the operating room cable assemblies described above; advancing a distal end portion of an electrical stimulation lead into the patient with a proximal end portion of the electrical stimulation lead extending outward from the patient, wherein the distal end portion of the electrical stimulation lead is advanced to a position where a plurality of electrodes disposed along the distal end portion of the electrical stimulation lead are in proximity to a target stimulation location; placing the proximal end portion of the electrical stimulation lead into the lead connector of the operating room cable assembly while the contact assembly is in the load position; and allowing the contact assembly to return to the lock position to lock the proximal end portion of the lead in the lead connector.


Another embodiment is a method for performing a trial stimulation on a patient. The method includes providing any of the operating room cable assemblies described above; advancing a distal end portion of an electrical stimulation lead into the patient with a proximal end portion of the electrical stimulation lead extending outward from the patient, wherein the distal end portion of the electrical stimulation lead is advanced to a position where a plurality of electrodes disposed along the distal end portion of the electrical stimulation lead are in proximity to a target stimulation location; coupling the lead to a lead extension; placing a proximal end portion of the lead extension into the lead connector of the operating room cable assembly while the contact assembly is in the load position; and allowing the contact assembly to return to the lock position to lock the proximal end portion of the lead extension in the lead connector.





BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.


For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:



FIG. 1 is a schematic view of one embodiment of an electrical stimulation system that includes a paddle lead electrically coupled to a control module, according to the invention;



FIG. 2 is a schematic view of one embodiment of an electrical stimulation system that includes a percutaneous lead electrically coupled to a control module, according to the invention;



FIG. 3A is a schematic view of one embodiment of the control module of FIG. 1 configured and arranged to electrically couple to an elongated device, according to the invention;



FIG. 3B is a schematic view of one embodiment of a lead extension configured and arranged to electrically couple the elongated device of FIG. 2 to the control module of FIG. 1, according to the invention;



FIG. 4 is a schematic illustration of components of one embodiment of a trial stimulation system, according to the invention;



FIG. 5A is a schematic perspective view of one embodiment of an operating room cable assembly, according to the invention;



FIG. 5B is a schematic perspective view of a lead connector of the operating room cable assembly of FIG. 5A, according to the invention;



FIG. 5C is a schematic side view of the lead connector of the operating room cable assembly of FIG. 5A, according to the invention;



FIG. 6A is a schematic exploded view of the lead connector of the operating room cable assembly of FIG. 5A, according to the invention;



FIG. 6B is a schematic cross-sectional view of the lead connector of the operating room cable assembly of FIG. 5A, according to the invention;



FIG. 6C is a schematic cut-away view of portions of the button, carriage, and contact assembly of the lead connector of the operating room cable assembly of FIG. 5A, according to the invention; and



FIG. 7 is a schematic overview of one embodiment of components of a stimulation system, including an electronic subassembly disposed within a control module, according to the invention.





DETAILED DESCRIPTION

The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to a push-button lead connector for an operating room cable assembly for use with an implantable electrical stimulation system, as well as methods of making and using the operating room cable assembly.


Suitable implantable electrical stimulation systems include, but are not limited to, a least one lead with one or more electrodes disposed along a distal end of the lead and one or more terminals disposed along the one or more proximal ends of the lead. Leads include, for example, percutaneous leads, paddle leads, and cuff leads. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,949,395; 7,244,150; 7,672,734; 7,761,165; 7,974,706; 8,175,710; 8,224,450; and 8,364,278; and U.S. Patent Application Publication No. 2007/0150036, all of which are incorporated by reference.



FIG. 1 illustrates schematically one embodiment of an electrical stimulation system 100. The electrical stimulation system includes a control module (e.g., a stimulator or pulse generator) 102 and a lead 103 coupleable to the control module 102. The lead 103 includes a paddle body 104 and one or more lead bodies 106. In FIG. 1, the lead 103 is shown having two lead bodies 106. It will be understood that the lead 103 can include any suitable number of lead bodies including, for example, one, two, three, four, five, six, seven, eight or more lead bodies 106. An array 133 of electrodes, such as electrode 134, is disposed on the paddle body 104, and an array of terminals (e.g., 310 in FIG. 3A-3B) is disposed along each of the one or more lead bodies 106.


It will be understood that the electrical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the electrical stimulation system references cited herein. For example, instead of a paddle body, the electrodes can be disposed in an array at or near the distal end of a lead body forming a percutaneous lead.



FIG. 2 illustrates schematically another embodiment of the electrical stimulation system 100, where the lead 103 is a percutaneous lead. In FIG. 2, the electrodes 134 are shown disposed along the one or more lead bodies 106. In at least some embodiments, the lead 103 is isodiametric along a longitudinal length of the lead body 106.


The lead 103 can be coupled to the control module 102 in any suitable manner. In FIG. 1, the lead 103 is shown coupling directly to the control module 102. In at least some other embodiments, the lead 103 couples to the control module 102 via one or more intermediate devices (324 in FIG. 3B). For example, in at least some embodiments one or more lead extensions 324 (see e.g., FIG. 3B) can be disposed between the lead 103 and the control module 102 to extend the distance between the lead 103 and the control module 102. Other intermediate devices may be used in addition to, or in lieu of, one or more lead extensions including, for example, a splitter, an adaptor, or the like or combinations thereof. It will be understood that, in the case where the electrical stimulation system 100 includes multiple elongated devices disposed between the lead 103 and the control module 102, the intermediate devices may be configured into any suitable arrangement.


In FIG. 2, the electrical stimulation system 100 is shown having a splitter 107 configured and arranged for facilitating coupling of the lead 103 to the control module 102. The splitter 107 includes a splitter connector 108 configured to couple to a proximal end of the lead 103, and one or more splitter tails 109a and 109b configured and arranged to couple to the control module 102 (or another splitter, a lead extension, an adaptor, or the like).


With reference to FIGS. 1 and 2, the control module 102 typically includes a connector housing 112 and a sealed electronics housing 114. An electronic subassembly 110 and an optional power source 120 are disposed in the electronics housing 114. A control module connector 144 is disposed in the connector housing 112. The control module connector 144 is configured and arranged to make an electrical connection between the lead 103 and the electronic subassembly 110 of the control module 102.


The electrical stimulation system or components of the electrical stimulation system, including the paddle body 104, the one or more of the lead bodies 106, and the control module 102, are typically implanted into the body of a patient. The electrical stimulation system can be used for a variety of applications including, but not limited to deep brain stimulation, neural stimulation, spinal cord stimulation, muscle stimulation, and the like.


The electrodes 134 can be formed using any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes 134 are formed from one or more of: platinum, platinum iridium, palladium, palladium rhodium, or titanium.


Any suitable number of electrodes 134 can be disposed on the lead including, for example, four, five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, twenty-four, thirty-two, or more electrodes 134. In the case of paddle leads, the electrodes 134 can be disposed on the paddle body 104 in any suitable arrangement. In FIG. 1, the electrodes 134 are arranged into two columns, where each column has eight electrodes 134.


The electrodes of the paddle body 104 (or one or more lead bodies 106) are typically disposed in, or separated by, a non-conductive, biocompatible material such as, for example, silicone, polyurethane, polyetheretherketone (“PEEK”), epoxy, and the like or combinations thereof. The one or more lead bodies 106 and, if applicable, the paddle body 104 may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. The non-conductive material typically extends from the distal ends of the one or more lead bodies 106 to the proximal end of each of the one or more lead bodies 106.


In the case of paddle leads, the non-conductive material typically extends from the paddle body 104 to the proximal end of each of the one or more lead bodies 106. Additionally, the non-conductive, biocompatible material of the paddle body 104 and the one or more lead bodies 106 may be the same or different. Moreover, the paddle body 104 and the one or more lead bodies 106 may be a unitary structure or can be formed as two separate structures that are permanently or detachably coupled together.


Terminals (e.g., 310 in FIGS. 3A-3B) are typically disposed along the proximal end of the one or more lead bodies 106 of the electrical stimulation system 100 (as well as any splitters, lead extensions, adaptors, or the like) for electrical connection to corresponding connector contacts (e.g., 314 in FIG. 3A). The connector contacts are disposed in connectors (e.g., 144 in FIGS. 1-3B; and 322FIG. 3B) which, in turn, are disposed on, for example, the control module 102 (or a lead extension, a splitter, an adaptor, or the like). Electrically conductive wires, cables, or the like (not shown) extend from the terminals to the electrodes 134. Typically, one or more electrodes 134 are electrically coupled to each terminal. In at least some embodiments, each terminal is only connected to one electrode 134.


The electrically conductive wires (“conductors”) may be embedded in the non-conductive material of the lead body 106 or can be disposed in one or more lumens (not shown) extending along the lead body 106. In some embodiments, there is an individual lumen for each conductor. In other embodiments, two or more conductors extend through a lumen. There may also be one or more lumens (not shown) that open at, or near, the proximal end of the one or more lead bodies 106, for example, for inserting a stylet to facilitate placement of the one or more lead bodies 106 within a body of a patient. Additionally, there may be one or more lumens (not shown) that open at, or near, the distal end of the one or more lead bodies 106, for example, for infusion of drugs or medication into the site of implantation of the one or more lead bodies 106. In at least one embodiment, the one or more lumens are flushed continually, or on a regular basis, with saline, epidural fluid, or the like. In at least some embodiments, the one or more lumens are permanently or removably sealable at the distal end.



FIG. 3A is a schematic side view of one embodiment of a proximal end of one or more elongated devices 300 configured and arranged for coupling to one embodiment of the control module connector 144. The one or more elongated devices may include, for example, one or more of the lead bodies 106 of FIG. 1, one or more intermediate devices (e.g., a splitter, the lead extension 324 of FIG. 3B, an adaptor, or the like or combinations thereof), or a combination thereof.


The control module connector 144 defines at least one port into which a proximal end of the elongated device 300 can be inserted, as shown by directional arrows 312a and 312b. In FIG. 3A (and in other figures), the connector housing 112 is shown having two ports 304a and 304b. The connector housing 112 can define any suitable number of ports including, for example, one, two, three, four, five, six, seven, eight, or more ports.


The control module connector 144 also includes a plurality of connector contacts, such as connector contact 314, disposed within each port 304a and 304b. When the elongated device 300 is inserted into the ports 304a and 304b, the connector contacts 314 can be aligned with a plurality of terminals 310 disposed along the proximal end(s) of the elongated device(s) 300 to electrically couple the control module 102 to the electrodes (134 of FIG. 1) disposed on the paddle body 104 of the lead 103. Examples of connectors in control modules are found in, for example, U.S. Pat. Nos. 7,244,150 and 8,224,450, which are incorporated by reference.



FIG. 3B is a schematic side view of another embodiment of the electrical stimulation system 100. The electrical stimulation system 100 includes a lead extension 324 that is configured and arranged to couple one or more elongated devices 300 (e.g., one of the lead bodies 106 of FIGS. 1 and 2, the splitter 107 of FIG. 2, an adaptor, another lead extension, or the like or combinations thereof) to the control module 102. In FIG. 3B, the lead extension 324 is shown coupled to a single port 304 defined in the control module connector 144. Additionally, the lead extension 324 is shown configured and arranged to couple to a single elongated device 300. In alternate embodiments, the lead extension 324 is configured and arranged to couple to multiple ports 304 defined in the control module connector 144, or to receive multiple elongated devices 300, or both.


A lead extension connector 322 is disposed on the lead extension 324. In FIG. 3B, the lead extension connector 322 is shown disposed at a distal end 326 of the lead extension 324. The lead extension connector 322 includes a connector housing 328. The connector housing 328 defines at least one port 330 into which terminals 310 of the elongated device 300 can be inserted, as shown by directional arrow 338. The connector housing 328 also includes a plurality of connector contacts, such as connector contacts 340. When the elongated device 300 is inserted into the port 330, the connector contacts 340 disposed in the connector housing 328 can be aligned with the terminals 310 of the elongated device 300 to electrically couple the lead extension 324 to the electrodes (134 of FIGS. 1 and 2) disposed along the lead (103 in FIGS. 1 and 2).


In at least some embodiments, the proximal end of the lead extension 324 is similarly configured and arranged as a proximal end of the lead 103 (or other elongated device 300). The lead extension 324 may include a plurality of electrically conductive wires (not shown) that electrically couple the connector contacts 340 to a proximal end 348 of the lead extension 324 that is opposite to the distal end 326. In at least some embodiments, the conductive wires disposed in the lead extension 324 can be electrically coupled to a plurality of terminals (not shown) disposed along the proximal end 348 of the lead extension 324. In at least some embodiments, the proximal end 348 of the lead extension 324 is configured and arranged for insertion into a connector disposed in another lead extension (or another intermediate device). In other embodiments (and as shown in FIG. 3B), the proximal end 348 of the lead extension 324 is configured and arranged for insertion into the control module connector 144.


Turning to FIG. 4, during implantation of the lead into a patient it is sometimes desirable to test the positioning or functionality of the electrodes within the patient prior to completion of the implantation. One way to test electrode positioning or functionality is to implant an electrode-including distal end portion of a lead (and, optionally, one or more lead extensions) into the patient. The proximal end portion of the lead (or lead extension) can then be electrically coupled to a trial stimulator that is disposed external to the patient to perform trial stimulations using the electrodes. Once it is determined that the electrodes are properly positioned and functioning within desired parameters, the trial stimulator can be decoupled from the proximal end portion of the lead (or lead extension) and replaced with an implantable control module, and the implantation can be completed.


In some embodiments, the trial stimulations can continue for two, four, six, eight, twelve, or more hours or for one, two, three, four, five or more days. In these instances, the patient may be in a hospital or other care facility. In some embodiments, the trial stimulations may continue for an extended period (e.g., 2-10 days or more) where the patient is sent home with the lead, cable, and trial stimulator to assess the effectiveness of the therapy to determine if a permanent implanted system will be effective in treating the medical condition. During the trial stimulations, the lead can be electrically coupled to the trial stimulator by electrically coupling the proximal end portion of the lead (or lead extension) to an operating room cable (“cable”) which, in turn, is electrically coupled to the trial stimulator. In some cases, when multiple leads are implanted into a patient, multiple leads (or lead extensions) may be coupled to the cable.



FIG. 4 is a schematic view of one embodiment of a trial stimulation arrangement 400 that includes a lead 403, a trial stimulator 448, and an operating room cable assembly 450, that couples the lead 403 to the trial stimulator 448. The lead 403 includes an array of electrodes 434 and an array of terminals 410. The terminals 410 are configured and arranged to couple the electrodes 434 to the trial stimulator 448 when the operating room cable assembly 450 is coupled to each of the lead 403 and the trial stimulator 448.


During operation, the electrodes 434 are disposed internal to the patient, while the terminals 410 remain external to the patient, as shown in FIG. 4 by a line 462 schematically representing patient skin. Optionally, the trial stimulation arrangement 400 includes one or more additional devices (e.g., a lead extension, an operating room cable extension, a splitter, an adaptor, or the like or any combination thereof). For example, the trial stimulation arrangement can include a lead extension which is coupleable to, and between, the lead 403 and the operating room cable assembly 450.


The operating room cable assembly 450 includes an elongated body 458 having a first end portion 454 and an opposing second end portion 456, a lead connector 452 with connector contacts, and an optional trial stimulator connector 460 optionally with terminals (a trial stimulator connector and terminals are not needed if the operating room cable assembly is permanently wired, or otherwise permanently attached, to the trial stimulator). Conductors (not shown) extend from the connector contacts of the lead connector to the terminals of the trial stimulator connector. The lead connector 452 is disposed along the first end portion 454 of the operating room cable assembly 450 and the connector contacts within the lead connector are coupleable to the terminals 434 of the lead 403 (or lead extension). The trial stimulator connector 460 is disposed along the second end portion 456 of the operating room cable assembly 450 and is coupleable to the trial stimulator 448, either directly or via one or more operating room cable extensions. Any suitable terminals can be used in the operating room cable assembly including rings, c-shaped contacts, plate contacts, pogo pins, and the like. Examples of terminals can be found in, for example, U.S. Pat. Nos. 7,539,542 and 8,849,396; U.S. Patent Application Publication No. 2013/0098678; and U.S. patent application Ser. No. 14/330,330, all of which are incorporated herein by reference.


Conventionally, the lead connectors of the operating room cable assembly are relatively large, bulky, and heavy. In some instances, conventional lead connectors may require two hands to operate. In some instances, it may not be clear to surgical personnel how to load a lead into the lead connector or how to “lock” the lead within the lead connector.


In the description below, leads will be referred to in connection with the lead connector. It will be understood, however, that a lead extension can be used in place of any of the leads for coupling to the lead connector with a lead coupled, in turn, to the lead extension.


A lead connector for use with an operating room cable assembly (or as a lead connector on a lead extension) can include a simpler, quicker, and easier locking-unlocking mechanism. One embodiment of an operating room cable assembly 550 with an elongated body 558, a lead connector 552, and trial stimulator connector 560 is illustrated in FIG. 5A. Any suitable trial stimulator connector 560 and elongated body 558 can be used including, but not limited to, those used for conventional or existing operating room cable assemblies. For example, the elongated body may include multiple conductors extending within a non-conductive sheath or jacket. The trial stimulator connector can be any standard or non-standard connector with multiple contacts for connecting to a trial stimulator. Alternatively, the operating room cable assembly 560 is permanently connected to the trial stimulator and does not include a trial stimulator connector.


The lead connector 552, illustrated in close-up views in FIGS. 5B and 5C, includes a housing 570 and a button 572 that can be pushed toward a center of the lead connector to a “load position” (see, FIGS. 5B, 5C, and 6B) for inserting or removing a lead (or lead extension). When the button 572 is released, the button is biased to move away from the center of the lead connector to a “lock position” to lock the lead in the lead connector. The housing 570 includes an opening 574 for insertion of the lead. Optionally, a visually distinctive marking 576 can be placed around the opening 574 to facilitate visual identification of the opening 574 and insertion of the lead. For example, the marking 574 can be in a color distinguishable from the surrounding portions of the housing 570. The elongated body 558 containing conductors extends from the housing 570 and may include a boot 578 to provide stability or prevent breakage at the exit from the housing and may incorporate a strain relief arrangement.



FIG. 6A illustrates an exploded view of one embodiment of the lead connector 552; FIG. 6B illustrates a cross-sectional view of this embodiment in the load position; and FIG. 6C illustrates a cut-away view of a portion (approximately one half) of selected components of the lead connector 552. In addition to the housing 570 and the button 572, the lead connector 570 includes a contact assembly 580, a lead lumen housing 582, and one or more springs 584. The button, 572, housing 570, and lead lumen housing 582 can be made of any suitable material including, but not limited to, plastic materials such as silicone, polyurethane, or the like or combinations thereof. In at least some embodiments, the button, 572, housing 570, and lead lumen housing 582 are made solely of non-conductive materials. In some embodiments, the housing 570 and lead lumen housing 582 are formed as a single piece and, in other embodiments, these two components are separate pieces.


The contact assembly 580 includes a base 590 and multiple contacts 592 attached to the base. The contact assembly 580 is movable relative to the housing 570 and can be moved to a load position for receiving the lead. The contact assembly 580 is biased to a lock position in which the contact assembly the engages a portion of a lead or lead extension within the lead lumen to hold or lock the portion of the lead or lead extension within the lead connector 552.


The base 590 of the contact assembly 580 can be made of any suitable non-conductive material such as, for example, polyimide, epoxy, other printed circuit board materials, flex circuit materials, other plastics, or the like or combinations thereof. The contacts 592 are made of metal or other conductive material and are positioned to engage the terminals of a lead (or lead extension) when the proximal portion of the lead (or lead extension) is properly and fully inserted in the lead connector 570 and the button 572 is in the lock position. As explained further below, the contact assembly 580 is coupled to the button 572 and moves with the button 572 to engage the lead (or lead extension) in the lock position or disengage from the lead (or lead extension) in the load position. Optionally, in the lock position, the contacts 580 may compress or otherwise engage the terminals of the lead to resist removal of the proximal portion of the lead from the lead connector 570.


In the illustrated embodiment, the contacts 592 are “M” shaped pins, but any other suitably shaped contact can be used. Each contact 592 is individually electrically coupled (for example, directly coupled or coupled through a wire) to one of multiple conductors 594 (FIG. 6B) that extend from the lead connector 552 through the elongated body 558 (FIG. 5A) and to corresponding contacts of the trial stimulator connector 560 (FIG. 5A).


As best illustrated in FIG. 6B, the lead lumen housing 582 and the housing 572 define a lead lumen 586 that extends into the lead connector 552 from the opening 574 and is arranged for receiving a proximal end portion of the lead (or lead extension). Optionally, a stylet opening 575 and stylet lumen 587 can also be defined so that a stylet can be inserted through the stylet opening 575 and stylet lumen 587 into the proximal end of the lead (or lead extension). The lead lumen housing 582 and housing 572 also define contact openings 596 through which the contacts 592 can pass as the contacts move from the lock position to the load position and vice versa.


The button 572 includes a carriage 588 to which the contact assembly 580 is attached. Any suitable method of attachment can be used including, but not limited to, screws 594, other fasteners, adhesive, or the like or the carriage 584 and the base 590 of the contact assembly 580 can be formed (e.g., molded) together with, for example, the contacts inserted or otherwise disposed in the combined arrangement. In some embodiments, the button 572 and carriage 588, instead of being a single, integral piece as illustrated in FIG. 6B, can be made of two or more parts that are attached together by fasteners, adhesive, or the like.


In at least some embodiments, the springs 584 (FIG. 6A) reside between the carriage 588 and the housing 570 and urge or bias the contact assembly 580 and the button 572 to the lock position. In some embodiments, the housing 570 may include platforms or receptacles for the springs 584. As the button 572 is pressed to the load position, the contact assembly 580 moves away from the lead lumen 586. When the button 572 is released the springs 584 urge or bias the contact assembly 580 and the button 572 to the lock position with the contact assembly 580 urged toward the lead lumen 586.


Optionally, the carriage 588 includes a lead engagement portion 589 that passes through an opening 577 in the lead lumen housing 582 to engage, or press against, a lead present within the lead lumen 586 to facilitate locking the lead within the lead lumen. The illustrated embodiment has a single lead engagement portion 589, but it will be understood that additional lead engagement portions can be used and may be part of the contact assembly 580 instead of the carriage 588.



FIG. 7 is a schematic overview of one embodiment of components of an electrical stimulation system 700 including an electronic subassembly 710 disposed within a control module. It will be understood that the electrical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the stimulator references cited herein.


Some of the components (for example, a power source 712, an antenna 718, a receiver 702, and a processor 704) of the electrical stimulation system can be positioned on one or more circuit boards or similar carriers within a sealed housing of an implantable pulse generator, if desired. Any power source 712 can be used including, for example, a battery such as a primary battery or a rechargeable battery. Examples of other power sources include super capacitors, nuclear or atomic batteries, mechanical resonators, infrared collectors, thermally-powered energy sources, flexural powered energy sources, bioenergy power sources, fuel cells, bioelectric cells, osmotic pressure pumps, and the like including the power sources described in U.S. Pat. No. 7,437,193, incorporated herein by reference.


As another alternative, power can be supplied by an external power source through inductive coupling via the optional antenna 718 or a secondary antenna. The external power source can be in a device that is mounted on the skin of the user or in a unit that is provided near the user on a permanent or periodic basis.


If the power source 712 is a rechargeable battery, the battery may be recharged using the optional antenna 718, if desired. Power can be provided to the battery for recharging by inductively coupling the battery through the antenna to a recharging unit 716 external to the user. Examples of such arrangements can be found in the references identified above.


In one embodiment, electrical current is emitted by the electrodes 134 on the paddle or lead body to stimulate nerve fibers, muscle fibers, or other body tissues near the electrical stimulation system. The processor 704 is generally included to control the timing and electrical characteristics of the electrical stimulation system. For example, the processor 704 can, if desired, control one or more of the timing, frequency, strength, duration, and waveform of the pulses. In addition, the processor 704 can select which electrodes can be used to provide stimulation, if desired. In some embodiments, the processor 704 selects which electrode(s) are cathodes and which electrode(s) are anodes. In some embodiments, the processor 704 is used to identify which electrodes provide the most useful stimulation of the desired tissue.


Any processor can be used and can be as simple as an electronic device that, for example, produces pulses at a regular interval or the processor can be capable of receiving and interpreting instructions from an external programming unit 708 that, for example, allows modification of pulse characteristics. In the illustrated embodiment, the processor 704 is coupled to a receiver 702 which, in turn, is coupled to the optional antenna 718. This allows the processor 704 to receive instructions from an external source to, for example, direct the pulse characteristics and the selection of electrodes, if desired.


In one embodiment, the antenna 718 is capable of receiving signals (e.g., RF signals) from an external telemetry unit 706 which is programmed by the programming unit 708. The programming unit 708 can be external to, or part of, the telemetry unit 706. The telemetry unit 706 can be a device that is worn on the skin of the user or can be carried by the user and can have a form similar to a pager, cellular phone, or remote control, if desired. As another alternative, the telemetry unit 706 may not be worn or carried by the user but may only be available at a home station or at a clinician's office. The programming unit 708 can be any unit that can provide information to the telemetry unit 706 for transmission to the electrical stimulation system 700. The programming unit 708 can be part of the telemetry unit 706 or can provide signals or information to the telemetry unit 706 via a wireless or wired connection. One example of a suitable programming unit is a computer operated by the user or clinician to send signals to the telemetry unit 706.


The signals sent to the processor 704 via the antenna 718 and the receiver 702 can be used to modify or otherwise direct the operation of the electrical stimulation system. For example, the signals may be used to modify the pulses of the electrical stimulation system such as modifying one or more of pulse duration, pulse frequency, pulse waveform, and pulse strength. The signals may also direct the electrical stimulation system 700 to cease operation, to start operation, to start charging the battery, or to stop charging the battery. In other embodiments, the stimulation system does not include the antenna 718 or receiver 702 and the processor 704 operates as programmed.


Optionally, the electrical stimulation system 700 may include a transmitter (not shown) coupled to the processor 704 and the antenna 718 for transmitting signals back to the telemetry unit 706 or another unit capable of receiving the signals. For example, the electrical stimulation system 700 may transmit signals indicating whether the electrical stimulation system 700 is operating properly or not or indicating when the battery needs to be charged or the level of charge remaining in the battery. The processor 704 may also be capable of transmitting information about the pulse characteristics so that a user or clinician can determine or verify the characteristics.


The above specification provides a description of the manufacture and use of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.

Claims
  • 1. An operating room cable assembly for an electrical stimulation system, the operating room cable assembly comprising: a lead connector comprising a housing having a first opening comprising a lead lumen housing defining a lead lumen extending within the housing from the first opening and configured to receive a portion of a lead or lead extension,a button comprising a first portion having a surface exposed for engagement by a user and a second portion attached to the first portion and disposed within the housing, wherein at least a portion of the lead lumen housing is disposed between the first portion and the second portion of the button, anda contact assembly coupled to the second portion of the button and disposed within the housing, wherein the button and contact assembly are configured for manual movement, relative to the housing, between a lock position and a load position and are biased to return to the lock position, wherein the contact assembly comprises a plurality of contacts that are configured to engage a portion of a lead or lead extension within the lead lumen in the lock position and to disengage from the portion of the lead or lead extension within the lead lumen when the contact assembly is moved from the lock position to the load position.
  • 2. The operating room cable assembly of claim 1, wherein the contact assembly comprises at least four independent contacts.
  • 3. The operating room cable assembly of claim 1, wherein the second portion of the button comprises a carriage and the contact assembly is fastened to the carriage.
  • 4. The operating room cable assembly of claim 3, wherein the carriage comprises a lead engagement portion that is configured to engage the portion of the lead or lead extension in the lead lumen when the contact assembly is in the lock position to facilitate retention of the lead or lead extension.
  • 5. The operating room cable assembly of claim 1, further comprising an elongated body coupled to, and extending from, the lead connector and comprising a plurality of conductors, wherein each of the conductors is coupled to at least one of the contacts of the contact assembly of the lead connector.
  • 6. The operating room cable assembly of claim 5, further comprising a trial stimulator connector coupled to the elongated body and comprising at least one contact coupled to the conductors of the elongated body.
  • 7. The operating room cable assembly of claim 1, wherein the lead connector further comprises at least one spring disposed between the contact assembly and the housing and configured to bias the contact assembly to the lock position.
  • 8. The operating room cable assembly of claim 1, wherein the lead lumen housing further defines a plurality of contact openings that intersect the lead lumen and through which the contacts of the contact assembly move when the contact assembly moves between the load position and the lock position.
  • 9. The operating room cable assembly of claim 1, wherein the lead connector further comprises a stylet lumen extending inwardly from a second opening in the housing opposite the first opening, wherein the stylet lumen intersects the lead lumen.
  • 10. The operating room cable assembly of claim 1, wherein the lead connector further comprises a visually distinctive marking disposed on the housing around at least a portion of the first opening.
  • 11. The operating room cable assembly of claim 1, wherein the contacts are “M” shaped pins.
  • 12. The operating room cable assembly of claim 1, wherein the lead connector further comprises at least one spring disposed between the button and the housing and configured to bias the button to the lock position.
  • 13. A trial stimulation system, comprising: a trial stimulator; andthe operating room cable assembly of claim 5 coupleable, or coupled, to the trial stimulator.
  • 14. The trial stimulation system of claim 13, wherein the operating room cable assembly further comprises a trial stimulator connector coupled to the elongated body and coupleable to the trial stimulator.
  • 15. The trial stimulation system of claim 13, wherein the elongated body of the operating room cable assembly is permanently attached to the trial stimulator.
  • 16. The trial stimulation system of claim 13, further comprising a lead coupleable to the lead connector of the operating room cable assembly.
  • 17. The trial stimulation system of claim 16, further comprising a lead extension coupleable to the lead and the lead connector of the operating room cable assembly.
  • 18. An insertion kit comprising: the operating room cable assembly of claim 1; andat least one electrical stimulation lead, each of the at least one electrical stimulation lead having a distal end portion and a proximal end portion and comprising a plurality of electrodes disposed along the distal end portion of the electrical stimulation lead,a plurality of terminals disposed along the proximal end portion of the electrical stimulation lead, anda plurality of conductors coupling the electrodes to the terminals,wherein the proximal end portion of the electrical stimulation lead is insertable into the lead lumen of the lead connector of the operating room cable assembly.
  • 19. A method for performing a trial stimulation on a patient, the method comprising: providing the operating room cable assembly of claim 1;advancing a distal end portion of an electrical stimulation lead into the patient with a proximal end portion of the electrical stimulation lead extending outwardly from the patient, wherein the distal end portion of the electrical stimulation lead is advanced to a position where a plurality of electrodes disposed along the distal end portion of the electrical stimulation lead are in proximity to a target stimulation location;inserting the proximal end portion of the electrical stimulation lead into the lead lumen of the lead connector of the operating room cable assembly while the contact assembly is in the load position; andallowing the contact assembly to return to the lock position to lock the proximal end portion of the electrical stimulation lead in the lead lumen of the lead connector.
  • 20. A method for performing a trial stimulation on a patient, the method comprising: providing the operating room cable assembly of claim 1;advancing a distal end portion of an electrical stimulation lead into the patient with a proximal end portion of the electrical stimulation lead extending outwardly from the patient, wherein the distal end portion of the electrical stimulation lead is advanced to a position where a plurality of electrodes disposed along the distal end portion of the electrical stimulation lead are in proximity to a target stimulation location;coupling the electrical stimulation lead to a lead extension;inserting a proximal end portion of the lead extension into the lead lumen of the lead connector of the operating room cable assembly while the contact assembly is in the load position; andallowing the contact assembly to return to the lock position to lock the proximal end portion of the lead extension in the lead connector.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/132,018, filed Sep. 14, 2018, which issued as U.S. Pat. No. 11,045,656, which claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/559,195, filed Sep. 15, 2017, both of which are incorporated herein by reference.

US Referenced Citations (459)
Number Name Date Kind
3222471 Steinkamp Dec 1965 A
3601747 Prall et al. Aug 1971 A
3718142 Mulier Feb 1973 A
3757789 Shanker Sep 1973 A
3771106 Matsumoto et al. Nov 1973 A
3908668 Bolduc Sep 1975 A
3951154 Hartlaub Apr 1976 A
3990727 Gallagher Nov 1976 A
4003616 Springer Jan 1977 A
4112953 Shanker et al. Sep 1978 A
4142532 Ware Mar 1979 A
4180078 Anderson Dec 1979 A
4245642 Skubitz et al. Jan 1981 A
4259962 Peers-Trevarton Apr 1981 A
4310001 Comben Jan 1982 A
4364625 Baker et al. Dec 1982 A
4367907 Buck Jan 1983 A
4411276 Dickhudt et al. Oct 1983 A
4411277 Dickhudt Oct 1983 A
4461194 Moore Jul 1984 A
4466441 Skubitz et al. Aug 1984 A
4516820 Kuzma May 1985 A
RE31990 Sluetz et al. Sep 1985 E
4540236 Peers-Trevarton Sep 1985 A
4602624 Naples et al. Jul 1986 A
4603696 Cross, Jr. et al. Aug 1986 A
4614395 Peers-Trevarton Sep 1986 A
4630611 King Dec 1986 A
4695116 Bailey et al. Sep 1987 A
4695117 Kysiak Sep 1987 A
4712557 Harris Dec 1987 A
4715380 Harris Dec 1987 A
4744370 Harris May 1988 A
4784141 Peers-Trevarton Nov 1988 A
4832032 Schneider May 1989 A
4840580 Saell et al. Jun 1989 A
4850359 Putz Jul 1989 A
4860750 Frey et al. Aug 1989 A
4867708 Iizuka Sep 1989 A
4869255 Putz Sep 1989 A
4898173 Daglow et al. Feb 1990 A
4899753 Inoue et al. Feb 1990 A
4942876 Gotthardt Jul 1990 A
4951687 Ufford et al. Aug 1990 A
4995389 Harris Feb 1991 A
5000177 Hoffman et al. Mar 1991 A
5000194 van den Honert et al. Mar 1991 A
5007435 Doan et al. Apr 1991 A
5007864 Stutz, Jr. Apr 1991 A
5069209 Posin Dec 1991 A
5070605 Daglow et al. Dec 1991 A
5082453 Stutz, Jr. Jan 1992 A
5086773 Ware Feb 1992 A
5135001 Sinofsky et al. Aug 1992 A
5193539 Schulman et al. Mar 1993 A
5193540 Schulman et al. Mar 1993 A
5201865 Kuehn Apr 1993 A
5241957 Camps et al. Sep 1993 A
5252090 Giurtino et al. Oct 1993 A
5261395 Oleen et al. Nov 1993 A
5312439 Loeb May 1994 A
5324312 Stokes et al. Jun 1994 A
5330521 Cohen Jul 1994 A
5336246 Dantanarayana Aug 1994 A
5348481 Ortiz Sep 1994 A
5354326 Comben et al. Oct 1994 A
5358514 Schulman et al. Oct 1994 A
5368496 Ranalletta et al. Nov 1994 A
5374279 Duffin, Jr. et al. Dec 1994 A
5374285 Vaiani et al. Dec 1994 A
5383913 Schiff Jan 1995 A
5413595 Stutz, Jr. May 1995 A
5433734 Stokes et al. Jul 1995 A
5435731 Kang Jul 1995 A
5458629 Baudino et al. Oct 1995 A
5486202 Bradshaw Jan 1996 A
5489225 Julian Feb 1996 A
5509928 Acken Apr 1996 A
5522874 Gates Jun 1996 A
5534019 Paspa Jul 1996 A
5545188 Bradshaw et al. Aug 1996 A
5545189 Fayram Aug 1996 A
5582180 Manset et al. Aug 1996 A
5560358 Arnold et al. Oct 1996 A
5679026 Fain et al. Oct 1997 A
5683433 Carson Nov 1997 A
5711316 Elsberry et al. Jan 1998 A
5713922 King Feb 1998 A
5720631 Carson et al. Feb 1998 A
5730628 Hawkins Mar 1998 A
5755743 Volz et al. May 1998 A
5766042 Ries et al. Jun 1998 A
5782892 Castle Jul 1998 A
5796044 Cobian et al. Aug 1998 A
5800350 Coppleson et al. Sep 1998 A
5800495 Machek et al. Sep 1998 A
5807144 Sivard Sep 1998 A
5837006 Ocel et al. Nov 1998 A
5843141 Bischoff et al. Dec 1998 A
5843148 Gijsbers et al. Dec 1998 A
5906634 Flynn et al. May 1999 A
5931861 Werner et al. Aug 1999 A
5938688 Schiff Aug 1999 A
5951595 Moberg et al. Sep 1999 A
5968082 Heil Oct 1999 A
5987361 Mortimer Nov 1999 A
5989077 Mast et al. Nov 1999 A
6006135 Kast et al. Dec 1999 A
6018684 Bartig et al. Jan 2000 A
6038479 Werner et al. Mar 2000 A
6038481 Werner et al. Mar 2000 A
6042432 Hashazawa et al. Mar 2000 A
6051017 Loeb et al. Apr 2000 A
6080188 Rowley et al. Jun 2000 A
6112120 Correas Aug 2000 A
6112121 Paul et al. Aug 2000 A
6125302 Kuzma Sep 2000 A
6134478 Spehr Oct 2000 A
6154678 Lauro Nov 2000 A
6161047 King et al. Dec 2000 A
6162101 Fischer et al. Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6167311 Rezai Dec 2000 A
6167314 Fischer, Sr. et al. Dec 2000 A
6175710 Kamaji et al. Jan 2001 B1
6181969 Gord Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6192278 Werner et al. Feb 2001 B1
6198969 Kuzma Mar 2001 B1
6208894 Schulman et al. Mar 2001 B1
6224450 Norton May 2001 B1
6271094 Boyd et al. Aug 2001 B1
6295944 Lovett Oct 2001 B1
6319021 Billman Nov 2001 B1
6321126 Kuzma Nov 2001 B1
6322559 Daulton et al. Nov 2001 B1
6343233 Werner et al. Jan 2002 B1
6364278 Lin et al. Apr 2002 B1
6370434 Zhang et al. Apr 2002 B1
6391985 Goode et al. May 2002 B1
6397108 Camps et al. May 2002 B1
6415168 Putz Jul 2002 B1
6428336 Akerfeldt Aug 2002 B1
6428368 Hawkins et al. Aug 2002 B1
6430442 Peters et al. Aug 2002 B1
6466824 Struble Oct 2002 B1
6473654 Chinn Oct 2002 B1
6498952 Mani et al. Dec 2002 B2
6510347 Borkan Jan 2003 B2
6516227 Meadows et al. Feb 2003 B1
6556873 Smits Apr 2003 B1
6564078 Marino et al. May 2003 B1
6604283 Kuzma Aug 2003 B1
6605094 Mann et al. Aug 2003 B1
6609029 Mann et al. Aug 2003 B1
6609032 Woods et al. Aug 2003 B1
6654641 Froberg Nov 2003 B1
6662035 Sochor Dec 2003 B2
6663570 Mott Dec 2003 B2
6671534 Putz Dec 2003 B2
6671553 Helland et al. Dec 2003 B1
6678564 Ketterl et al. Jan 2004 B2
6687538 Hrdlicka et al. Feb 2004 B1
6725096 Chinn et al. Apr 2004 B2
6741892 Meadows et al. May 2004 B1
6757039 Ma Jun 2004 B2
6757970 Kuzma et al. Jul 2004 B1
6799991 Williams et al. Oct 2004 B2
6805675 Gardeski et al. Oct 2004 B1
6854994 Stein et al. Feb 2005 B2
6878013 Behan Apr 2005 B1
6895276 Kast et al. May 2005 B2
6913478 Lamrey Jul 2005 B2
6921295 Sommer et al. Jul 2005 B2
6968235 Belden et al. Nov 2005 B2
6980863 van Venrooj et al. Dec 2005 B2
7027852 Helland Apr 2006 B2
7047084 Erickson et al. May 2006 B2
7058452 Dahberg Jun 2006 B2
7069081 Biggs et al. Jun 2006 B2
7083474 Fleck et al. Aug 2006 B1
7108549 Lyu et al. Sep 2006 B2
7110827 Sage et al. Sep 2006 B2
7128600 Osypka Oct 2006 B2
7155283 Ries et al. Dec 2006 B2
7164951 Ries et al. Jan 2007 B2
7168165 Calzada et al. Jan 2007 B2
7191009 Laske et al. Mar 2007 B2
7195523 Naviaux Mar 2007 B2
7203548 Whitehurst et al. Apr 2007 B2
7225034 Ries et al. May 2007 B2
7231253 Tidemand et al. Jun 2007 B2
7241180 Rentas Jul 2007 B1
7242987 Holleman et al. Jul 2007 B2
7244150 Brase et al. Jul 2007 B1
7270568 Osypka Sep 2007 B2
7283878 Brostrom et al. Oct 2007 B2
7286882 Cole Oct 2007 B2
7287995 Stein et al. Oct 2007 B2
7292890 Whitehurst et al. Nov 2007 B2
7396335 Gardeski et al. Jul 2008 B2
7402083 Kast et al. Jul 2008 B2
7422487 Osypka Sep 2008 B2
7430958 Wong Oct 2008 B2
7437193 Parramon et al. Oct 2008 B2
7450997 Pianca et al. Nov 2008 B1
7489971 Franz Feb 2009 B1
7512446 Honeck Mar 2009 B2
7516447 Drew Mar 2009 B2
7526339 Lahti et al. Apr 2009 B2
7539542 Malinowski May 2009 B1
7548788 Chinn et al. Jun 2009 B2
7554493 Rahman Jun 2009 B1
7583999 Bedenbaugh Sep 2009 B2
7585190 Osypka Sep 2009 B2
7590451 Tronnes et al. Sep 2009 B2
7650184 Walter Jan 2010 B2
7668601 Hegland et al. Feb 2010 B2
7672734 Anderson et al. Mar 2010 B2
7736191 Sochor Jun 2010 B1
7758384 Alexander et al. Jul 2010 B2
7761165 He et al. Jul 2010 B1
7761985 Hegland et al. Jul 2010 B2
7783359 Meadows Aug 2010 B2
7792590 Pianca et al. Sep 2010 B1
7798864 Barker et al. Sep 2010 B2
7803021 Brase Sep 2010 B1
7809446 Meadows Oct 2010 B2
7822477 Rey et al. Oct 2010 B2
7822482 Gerber Oct 2010 B2
7840188 Kurokawa Nov 2010 B2
7848802 Goetz Dec 2010 B2
7856707 Cole Dec 2010 B2
7860570 Whitehurst et al. Dec 2010 B2
7949395 Kuzma May 2011 B2
7974705 Zdeblick et al. Jul 2011 B2
7974706 Moffitt et al. Jul 2011 B2
7979140 Schulman Jul 2011 B2
8000808 Hegland et al. Aug 2011 B2
8019440 Kokones et al. Sep 2011 B2
8036755 Franz Oct 2011 B2
8041309 Kurokawa Oct 2011 B2
8046073 Pianca Oct 2011 B1
8046074 Barker Oct 2011 B2
8078280 Sage Dec 2011 B2
8099177 Dahlberg Jan 2012 B2
8100726 Harlan et al. Jan 2012 B2
8140163 Daglow et al. Mar 2012 B1
8140172 Jones et al. Mar 2012 B1
8167660 Dilmaghanian et al. May 2012 B2
8175710 He May 2012 B2
8190259 Smith et al. May 2012 B1
8206180 Kast et al. Jun 2012 B1
8224450 Brase Jul 2012 B2
8225504 Dye et al. Jul 2012 B2
8239042 Chinn et al. Aug 2012 B2
8271094 Moffitt et al. Sep 2012 B1
8295944 Howard et al. Oct 2012 B2
8301255 Barker Oct 2012 B2
8321025 Bedenbaugh Nov 2012 B2
8342887 Gleason et al. Jan 2013 B2
8359107 Pianca et al. Jan 2013 B2
8364278 Pianca et al. Jan 2013 B2
8391985 McDonald Mar 2013 B2
8412330 Kast et al. Apr 2013 B2
8527054 North Sep 2013 B2
8583237 Bedenbaugh Nov 2013 B2
8600507 Brase et al. Dec 2013 B2
8682439 DeRohan et al. Mar 2014 B2
8688235 Pianca et al. Apr 2014 B1
8784143 Edgell et al. Jul 2014 B2
8831742 Pianca et al. Sep 2014 B2
8849396 DeRohan et al. Sep 2014 B2
8849415 Bedenbaugh Sep 2014 B2
8897876 Sundaramurthy et al. Nov 2014 B2
8897891 Romero Nov 2014 B2
8968331 Sochor Mar 2015 B1
9101775 Barker Aug 2015 B2
9149630 Howard et al. Oct 2015 B2
9162048 Romero et al. Oct 2015 B2
9234591 Dilmaghanian et al. Jan 2016 B2
9270070 Pianca Feb 2016 B2
9289596 Leven Mar 2016 B2
9352147 Nguyen-Stella et al. May 2016 B2
9381348 Romero et al. Jul 2016 B2
9403022 Ries et al. Aug 2016 B2
9409032 Brase et al. Aug 2016 B2
9440066 Black Sep 2016 B2
9498618 Stetson et al. Nov 2016 B2
9498620 Romero et al. Nov 2016 B2
9504839 Leven Nov 2016 B2
9517338 Jiang et al. Dec 2016 B1
9604068 Malinowski Mar 2017 B2
9656093 Villarta et al. May 2017 B2
9770598 Malinowski et al. Sep 2017 B2
9855413 Vadlamudi et al. Jan 2018 B2
10195423 Jiang et al. Feb 2019 B2
11045656 Nageri Jun 2021 B2
20010023368 Black et al. Sep 2001 A1
20020143376 Chinn et al. Oct 2002 A1
20020156513 Borkan Oct 2002 A1
20020183817 Van Venrooij et al. Dec 2002 A1
20030163171 Kast et al. Aug 2003 A1
20040064164 Ries et al. Apr 2004 A1
20040230268 Huff et al. Nov 2004 A1
20040260373 Ries et al. Dec 2004 A1
20050015130 Gill Jan 2005 A1
20050027326 Ries et al. Feb 2005 A1
20050027327 Ries et al. Feb 2005 A1
20050038489 Grill Feb 2005 A1
20050043770 Hine et al. Feb 2005 A1
20050043771 Sommer et al. Feb 2005 A1
20050137665 Cole Jun 2005 A1
20050171587 Daglow et al. Aug 2005 A1
20050186829 Balsells Aug 2005 A1
20050272280 Osypka Dec 2005 A1
20060015163 Brown Jan 2006 A1
20060025841 McIntyre Feb 2006 A1
20060030918 Chinn Feb 2006 A1
20060167522 Malinowski Jul 2006 A1
20060224208 Naviaux Oct 2006 A1
20060247697 Sharma et al. Nov 2006 A1
20060247749 Colvin Nov 2006 A1
20060259106 Arnholt et al. Nov 2006 A1
20070042648 Balsells Feb 2007 A1
20070142889 Whitehurst et al. Jun 2007 A1
20070150036 Anderson Jun 2007 A1
20070161294 Brase et al. Jul 2007 A1
20070168007 Kuzma et al. Jul 2007 A1
20070203546 Stone et al. Aug 2007 A1
20070219551 Honour et al. Sep 2007 A1
20080077186 Thompson et al. Mar 2008 A1
20080103580 Gerber May 2008 A1
20080114230 Addis May 2008 A1
20080139031 Ries et al. Jun 2008 A1
20080177167 Janzig et al. Jul 2008 A1
20080208277 Janzig et al. Aug 2008 A1
20080208278 Janzig et al. Aug 2008 A1
20080208279 Janzig et al. Aug 2008 A1
20080215125 Farah et al. Sep 2008 A1
20080255647 Jensen et al. Oct 2008 A1
20080274651 Boyd et al. Nov 2008 A1
20090054941 Eggen et al. Feb 2009 A1
20090187222 Barker Jul 2009 A1
20090204192 Carlton et al. Aug 2009 A1
20090264943 Barker Oct 2009 A1
20090276021 Meadows et al. Nov 2009 A1
20090287191 Ferren et al. Nov 2009 A1
20100029127 Sjostedt Feb 2010 A1
20100030298 Martens et al. Feb 2010 A1
20100036468 Decre et al. Feb 2010 A1
20100057176 Barker Mar 2010 A1
20100070012 Chinn et al. Mar 2010 A1
20100076535 Pianca et al. Mar 2010 A1
20100077606 Black et al. Apr 2010 A1
20100082076 Lee et al. Apr 2010 A1
20100094387 Pianca et al. Apr 2010 A1
20100100152 Martens et al. Apr 2010 A1
20100268298 Moffitt et al. Oct 2010 A1
20100269338 Dye Oct 2010 A1
20100269339 Dye et al. Oct 2010 A1
20100287770 Padd et al. Nov 2010 A1
20110004267 Meadows Jan 2011 A1
20110005069 Pianca Jan 2011 A1
20110022100 Brase et al. Jan 2011 A1
20110047795 Turner et al. Mar 2011 A1
20110056076 Hegland et al. Mar 2011 A1
20110077699 Swanson et al. Mar 2011 A1
20110078900 Pianca et al. Apr 2011 A1
20110130803 McDonald Jun 2011 A1
20110130816 Howard et al. Jun 2011 A1
20110130817 Chen Jun 2011 A1
20110130818 Chen Jun 2011 A1
20110131808 Gill Jun 2011 A1
20110184480 Kast et al. Jul 2011 A1
20110238129 Moffitt et al. Sep 2011 A1
20110245903 Schulte et al. Oct 2011 A1
20110270330 Janzig et al. Nov 2011 A1
20110301665 Mercanzini et al. Dec 2011 A1
20110313500 Barker et al. Dec 2011 A1
20120016378 Pianca et al. Jan 2012 A1
20120035692 Cantlon et al. Feb 2012 A1
20120046710 DiGiore et al. Feb 2012 A1
20120053646 Brase et al. Mar 2012 A1
20120071937 Sundaramurthy et al. Mar 2012 A1
20120071949 Pianca et al. Mar 2012 A1
20120165911 Pianca Jun 2012 A1
20120185019 Schramm et al. Jul 2012 A1
20120197375 Pianca et al. Aug 2012 A1
20120203302 Moffit et al. Aug 2012 A1
20120203316 Moffitt et al. Aug 2012 A1
20120203320 DiGiore et al. Aug 2012 A1
20120203321 Moffitt et al. Aug 2012 A1
20120232603 Sage Sep 2012 A1
20120253443 Dilmaghanian et al. Oct 2012 A1
20120259386 DeRohan et al. Oct 2012 A1
20120316615 DiGiore et al. Dec 2012 A1
20130053864 Geroy et al. Feb 2013 A1
20130098678 Barker Apr 2013 A1
20130105071 DiGiore et al. May 2013 A1
20130109254 Klardie et al. May 2013 A1
20130116754 Sharma et al. May 2013 A1
20130149031 Changsrivong et al. Jun 2013 A1
20130197424 Bedenbaugh Aug 2013 A1
20130197602 Pianca et al. Aug 2013 A1
20130197603 Eiger Aug 2013 A1
20130218154 Carbunaru Aug 2013 A1
20130261684 Howard Oct 2013 A1
20130288501 Russell et al. Oct 2013 A1
20130304140 Derohan et al. Nov 2013 A1
20130317587 Barker Nov 2013 A1
20130325091 Pianca et al. Dec 2013 A1
20140039587 Romero Feb 2014 A1
20140088666 Goetz et al. Mar 2014 A1
20140142671 Moffitt et al. May 2014 A1
20140148885 DeRohan et al. May 2014 A1
20140180375 Pianca et al. Jun 2014 A1
20140350655 North Nov 2014 A1
20140353001 Romero et al. Dec 2014 A1
20140358207 Romero Dec 2014 A1
20140358208 Howard et al. Dec 2014 A1
20140358209 Romero et al. Dec 2014 A1
20140358210 Howard et al. Dec 2014 A1
20150018915 Leven Jan 2015 A1
20150021817 Romero et al. Jan 2015 A1
20150025609 Govea Jan 2015 A1
20150045864 Howard Feb 2015 A1
20150066120 Govea Mar 2015 A1
20150119965 Govea Apr 2015 A1
20150151113 Govea et al. Jun 2015 A1
20150209575 Black Jul 2015 A1
20150360023 Howard et al. Dec 2015 A1
20150374978 Howard et al. Dec 2015 A1
20160059019 Malinowski et al. Mar 2016 A1
20160082254 Moffitt et al. Mar 2016 A1
20160082255 Moffitt et al. Mar 2016 A1
20160129242 Malinowski May 2016 A1
20160129265 Malinowski May 2016 A1
20160158558 Shanahan et al. Jun 2016 A1
20160206891 Howard et al. Jul 2016 A1
20160220826 Funderburk Aug 2016 A1
20160228692 Steinke et al. Aug 2016 A1
20160296745 Govea et al. Oct 2016 A1
20160375238 Leven et al. Dec 2016 A1
20170072187 Howard et al. Mar 2017 A1
20170143978 Barker May 2017 A1
20170203104 Nageri et al. Jul 2017 A1
20170361108 Leven Dec 2017 A1
20180008832 Leven Jan 2018 A1
20180028820 Nageri Feb 2018 A1
20180093098 Nageri et al. Apr 2018 A1
20180214687 Nageri et al. Aug 2018 A1
20180243570 Malinowski et al. Aug 2018 A1
20180289968 Lopez Oct 2018 A1
20180369596 Funderburk Dec 2018 A1
20190030345 Funderburk Jan 2019 A1
20190083793 Nageri Mar 2019 A1
20190083794 Nageri Mar 2019 A1
20190103696 Conger Apr 2019 A1
Foreign Referenced Citations (21)
Number Date Country
0580928 Feb 1994 EP
0650694 Jul 1998 EP
0832667 Feb 2004 EP
1181947 Jan 2006 EP
1625875 Feb 2006 EP
2092952 Aug 2009 EP
1997032628 Sep 1997 WO
1999055411 Feb 2000 WO
2000038574 Jul 2000 WO
2001058520 Aug 2001 WO
2002068042 Sep 2002 WO
2004045707 Jun 2004 WO
2008018067 Feb 2008 WO
2008053789 May 2008 WO
2008100841 Aug 2008 WO
2009025816 Feb 2009 WO
2009102536 Aug 2009 WO
2009148939 Dec 2009 WO
2013162775 Oct 2013 WO
2014018092 Jan 2014 WO
2016077649 May 2016 WO
Non-Patent Literature Citations (2)
Entry
Official Communication for U.S. Appl. No. 16/132,018 dated Sep. 14, 2020.
International Search Report and Written Opinion for PCT Application No. PCT/US2018/051171 dated Dec. 19, 2018.
Related Publications (1)
Number Date Country
20210299454 A1 Sep 2021 US
Provisional Applications (1)
Number Date Country
62559195 Sep 2017 US
Continuations (1)
Number Date Country
Parent 16132018 Sep 2018 US
Child 17343559 US